STI Research Funding: Top 20 Institutions and Organizations

This chart lists the top twenty organizations funding STI diagnostic and vaccine research.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

STI Research Funding Distribution by Country of Institution

This map shows the funding distribution of STI vaccine and diagnostic funding by country of institution.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

STI Vaccine and Diagnostic R&D Funding by NIH IC and Topic

This chart shows STI vaccine and diagnostic R&D funding by NIH institutes and centers and by topic.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

STI Vaccine and Diagnostic R&D Funding by NIH IC

This pie chart provides a breakdown research & development funding for STI vaccines and diagnostics by NIH institutes and centers.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

STI Vaccine and Diagnostic R&D Funding by Pathogen

This table shows STI vaccine and diagnostic research & development funding by pathogen.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

STI Vaccine and Diagnostic R&D Funding by Topic

This pie chart shows research & development funding for STI vaccines and diagnostics by topic.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

STI Vaccine and Diagnostic R&D Funding by Sector

This pie chart shows research & development funding for STI vaccines and diagnostics by sector — public and philanthropic.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

Coalition to Accelerate Access to Long-Acting PrEP

The Coalition to Accelerate Access to Long-Acting PrEP brings together leading donors, agencies, and advocates aimed at a practical goal: jointly develop strategies and take coordinated action to identify and overcome access challenges to just-approved and future PrEP options. AVAC serves as the Secretariat.

Find more information here.

Access Enablers

This graphic presents key strategies for advocates to improve vaccine access, highlighting actions like influencing WHO guidelines, community education, addressing intellectual property barriers, and establishing voluntary access mechanisms.

From the Lab to the Jab

This graphic shows all the steps to cross or overcome in the development of a new product — research & development, intellectual property barriers, registration with regulatory bodies and the implementation of products — along with the important role can advocates play.